Page last updated: 2024-09-03

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Aura

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with Aura in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Bundel, D; Michotte, Y; Smolders, I; Vanderheyden, P1
Angelatou, F; Sotiriou, E; Tchekalarova, J1
Georgiev, V; Kambourova, T; Tchekalarova, J1

Reviews

1 review(s) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Aura

ArticleYear
Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy.
    CNS neuroscience & therapeutics, 2008,Winter, Volume: 14, Issue:4

    Topics: Angiotensin II; Animals; Avoidance Learning; Binding Sites; Epilepsy; Humans; Memory; Neuronal Plasticity; Receptors, Angiotensin; Synapses

2008

Other Studies

2 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Aura

ArticleYear
Down-regulation of dopamine D1 and D2 receptors in the basal ganglia of PTZ kindling model of epilepsy: effects of angiotensin IV.
    Brain research, 2004, Oct-22, Volume: 1024, Issue:1-2

    Topics: Angiotensin II; Animals; Basal Ganglia; Dopamine D2 Receptor Antagonists; Down-Regulation; Epilepsy; Kindling, Neurologic; Male; Mice; Mice, Inbred BALB C; Pentylenetetrazole; Protein Binding; Receptors, Dopamine D1; Receptors, Dopamine D2

2004
Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors.
    Brain research bulletin, 2001, Sep-15, Volume: 56, Issue:2

    Topics: Adenosine; Angiotensin II; Angiotensin III; Angiotensins; Animals; Brain; Convulsants; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Seizures; Xanthines

2001